MBX Biosciences, Inc. MBX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s operating lease right-of-use assets in other assets?
- MBX Biosciences, Inc. (MBX) reported operating lease right-of-use assets in other assets of $453K in Q1 2026.
- How has MBX Biosciences, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- MBX Biosciences, Inc.'s operating lease right-of-use assets in other assets increased by 397.8% year-over-year, from $91K to $453K.
- What is the long-term trend for MBX Biosciences, Inc.'s operating lease right-of-use assets in other assets?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s operating lease right-of-use assets in other assets has grown at a 46.8% compound annual growth rate (CAGR), from $226K to $487K.